The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Dry Eye Disease (DED)

Interventions

DRUG

3% trehalose

ophthalmic solution with 3% trehalose in sterile saline in multi dose preservative free bottles

Trial Locations (1)

Marshall B. Ketchum University, Fullerton

All Listed Sponsors

lead

Southern California College of Optometry at Marshall B. Ketchum University

OTHER